BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 6759217)

  • 1. Reversal of abnormalities in ocular fluorophotometry in insulin-dependent diabetes after five to nine months of improved metabolic control.
    White NH; Waltman SR; Krupin T; Santiago JV
    Diabetes; 1982 Jan; 31(1):80-5. PubMed ID: 6759217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sequential vitreous fluorophotometry in diabetes mellitus: a five-year prospective study.
    Waltman SR
    Trans Am Ophthalmol Soc; 1984; 82():827-49. PubMed ID: 6535330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ocular fluorophotometry in insulin-treated diabetic patients with and without retinopathy.
    Kjaergaard JJ; Ohrt V
    Int J Microcirc Clin Exp; 1983; 2(3):207-13. PubMed ID: 6381356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term kinetic vitreous fluorophotometry in normal and diabetic subjects.
    Knudsen LL; Olsen T; Nielsen-Kudsk F
    Acta Ophthalmol (Copenh); 1992 Oct; 70(5):570-7. PubMed ID: 1471478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitreous fluorophotometry in juvenile-onset diabetes mellitus.
    Krupin T; Waltman SR; Oestrich C; Santiago J; Ratzan S; Kilo C; Becker B
    Arch Ophthalmol; 1978 May; 96(5):812-4. PubMed ID: 655917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluorophotometry in juvenile-onset diabetes: long-term follow-up.
    Krupin T; Waltman SR
    Jpn J Ophthalmol; 1985; 29(2):139-45. PubMed ID: 4046222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ocular fluorophotometry in streptozotocin diabetes mellitus in the rat: effect of pancreatic islet isografts.
    Krupin T; Waltman SR; Scharp DW; Oestrich C; Feldman SD; Becker B; Ballinger WF; Lacy PE
    Invest Ophthalmol Vis Sci; 1979 Nov; 18(11):1185-90. PubMed ID: 116969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ocular fluorophotometry in the normal- and diabetic monkey.
    Jones CW; Cunha-Vaz JG; Zeimer RC; Rusin MM; Langenberg PW; Vygantas CM; Tso MO; Jonasson O
    Exp Eye Res; 1986 May; 42(5):467-77. PubMed ID: 3720865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitreous fluorophotometry in juvenile diabetics with and without retinopathy in relation to metabolic control: insulin antibodies and c-peptide levels.
    Kernell A; Ludvigsson J; Finnström K
    Acta Ophthalmol (Copenh); 1990 Aug; 68(4):415-20. PubMed ID: 2220357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of vitreous fluorophotometry to distinguish between diabetics with and without observable retinopathy: effect of vitreous abnormalities on the measurement.
    Prager TC; Chu HH; Garcia CA; Anderson RE; Field JB; Orzeck EA; Comstock JP
    Invest Ophthalmol Vis Sci; 1983 Jan; 24(1):57-65. PubMed ID: 6826315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on the pathophysiology of diabetic retinopathy. The blood-retinal barrier in diabetes.
    Cunha-Vaz JG
    Diabetes; 1983 May; 32 Suppl 2():20-7. PubMed ID: 6400666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitreous fluorophotometry in insulin-dependent diabetes mellitus. Correlation with microalbuminuria and diastolic blood pressure.
    Jackson WE; Chase HP; Garg SK; Bartlett DA; Hoops S; Harris S; Marshall G; Ishimoto BM
    Arch Ophthalmol; 1990 Dec; 108(12):1733-5. PubMed ID: 2256845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anterior chamber and vitreous fluorescein kinetics in normal and diabetic subjects.
    Knudsen LL; Nielsen-Kudsk F
    Acta Ophthalmol Scand; 1998 Aug; 76(4):396-400. PubMed ID: 9716323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitreous fluorophotometry in children with type I diabetes mellitus.
    Brooks AM; Keith CG; Court JM; Hill MA
    Aust J Ophthalmol; 1984 Feb; 12(1):39-43. PubMed ID: 6732657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mapping retinal fluorescein leakage with confocal scanning laser fluorometry of the human vitreous.
    Lobo CL; Bernardes RC; Santos FJ; Cunha-Vaz JG
    Arch Ophthalmol; 1999 May; 117(5):631-7. PubMed ID: 10326960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An 18-month vitreous fluorophotometric follow-up study in juvenile diabetics.
    Benitez del Castillo JM; Castillo A; Garcia Sanchez J; Ruibal JL; Reverte F; Ibarra JM
    Acta Ophthalmol (Copenh); 1993 Oct; 71(5):651-6. PubMed ID: 8109211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitreous fluorophotometry in patients with no or minimal diabetic retinopathy.
    Chahal P; Fallon TJ; Jennings SJ; Chowienczyk PJ; Kohner EM
    Diabetes Care; 1986; 9(2):134-9. PubMed ID: 3698779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitreous fluorescein accumulation determined by in vivo fluorophotometry and by vitreous extraction in normal and diabetic rats.
    Kaufmann F; Lacoste C
    Diabetologia; 1986 Mar; 29(3):175-80. PubMed ID: 3516774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Posterior vitreous fluorophotometry in diabetic patients with minimal or no retinopathy.
    Roy MS; Podgor MJ; Bungay P; Grunberger G; Carl J; Ellis D
    Retina; 1987; 7(3):170-6. PubMed ID: 3423432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitreous fluorophotometry in juvenile diabetes.
    Kernell A; Larsson Y; Ludvigsson J; Tenland T
    Acta Endocrinol Suppl (Copenh); 1980; 238():67-74. PubMed ID: 6933816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.